News | 13 March 2026
Nick Davies joins the Envair Technology team as our Sales Director
We’re delighted to welcome Nick, who joins our business with more than 20 years’ experience in senior leadership roles, bringing a proven track record of commercial growth and building high-performance teams.
The appointment comes at a time of sustained growth for us, as we are on track to exceed our £20m revenue target by 2030. Orders across our clean air product range, including Rigid Isolators, Fume Cupboards and Downflow Booths, have risen by almost 20% over the past twelve months, with staff numbers also increasing by 15%.
This growth has been fuelled by demand for Annex 1-compliant equipment and isolators, driven by the shift to Vaporised Hydrogen Peroxide (VHP) gassing technology across NHS, healthcare and pharmaceutical markets. Investment in UK university laboratory infrastructure, as part of the government’s Science and Technology Superpower agenda, is also seeing demand for fume cupboards increase, with major projects underway and further large-scale developments planned.
Nick Davies joins us from Medicom, where he supported the rollout of a major NHS mask contract during the Covid-19 pandemic and helped to establish the company as one of the top four FFP3 suppliers to the NHS. Prior to this, he spent 10 years at PPE specialist, Arco, working as a director in both divisional and national roles.
Nick says:
Envair Technology is respected worldwide as a leading clean air and containment manufacturing specialist and I’m delighted to join the team at such an exciting time. The company is serious about investing in growth – to deepen its sector expertise, enhance its manufacturing capability and further strengthen its aftermarket support services. My focus is on building a solutions-driven team that supports global organisations across the healthcare, pharmaceutical and education sectors – working in close partnership to enable the safe, compliant and effective handling of highly potent APIs and the advancement of next-generation drug development.”
Andrew Ellison, our Managing Director, adds:
Nick brings a wealth of experience in delivering sustained commercial growth within highly regulated markets. His deep understanding of our priority sectors, combined with his ability to build high-value relationships with world-leading organisations, makes him ideally placed to lead our next phase of growth. This is a pivotal year for Envair Technology as we continue to scale in the UK, Europe and beyond, and we’re delighted to have Nick on board.”
Envair Technology orders are up 20% year on year as demand for clean air solutions increases across higher education, pharma and healthcare sectors.




